Company Filing History:
2 out of 321 
2 out of 81 
2 out of 55 
Years Active: 2023-2025
Title: Christophe Desterke: Innovator in Cancer Treatment
Introduction
Christophe Desterke is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer treatment through his innovative approaches and patented methods. With a total of 2 patents, Desterke is recognized for his work in developing therapeutic strategies that target cancers expressing embryonic antigens.
Latest Patents
Desterke's latest patents focus on methods and compositions for treating cancers. He provides a new therapeutic strategy that involves administering engineered fetal stem cells carrying cancer-associated fetal neo-antigens. This method includes the simultaneous, separate, or sequential administration of these stem cells along with a compound that activates the immune response, creating a combined preparation aimed at treating subjects suffering from cancer.
Career Highlights
Throughout his career, Christophe Desterke has worked with prestigious institutions such as Université Paris-Saclay and Université Paris Cité. His research has been pivotal in advancing the understanding and treatment of cancer, particularly in the context of utilizing fetal stem cells for therapeutic purposes.
Collaborations
Desterke has collaborated with notable colleagues in his field, including Frank Griscelli and Annelise Bennaceur Griscelli. These collaborations have further enriched his research and contributed to the development of innovative cancer treatments.
Conclusion
Christophe Desterke stands out as an influential inventor in the realm of cancer treatment, with his patented methods offering promising avenues for therapeutic intervention. His work continues to inspire advancements in medical science and cancer therapy.